Try our Advanced Search for more refined results
Cannabis
Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.
Sign up for a 7-day FREE trial today!
Latest News in Cannabis
-
February 27, 2026
Altria-Juul Judge Details Class Cert. Decision In Antitrust Row
"Common, predominant questions abound" as to whether e-cigarette company Juul and tobacco giant Altria schemed to have Altria exit the e-cigarette market, a California federal judge has said in explaining why he granted class certification to classes of purchasers in antitrust litigation over Altria's past investment in Juul.
-
February 27, 2026
3rd Circ. Preview: Janssen, Penn State Prof. Seek Relief
A packed March argument calendar will put several high‑stakes disputes before the Third Circuit, including a billion‑dollar False Claims Act judgment and challenges at the intersection of academic freedom, DEI programming, cannabis‑sector finance and campus Title IX procedures.
-
February 27, 2026
Insurer Sued For Denying Life Insurance Claim Over Kratom Use
An Ohio woman sued Lincoln National Life Insurance Co. in federal court Friday, alleging that the insurer wrongly denied her life insurance claim because her late husband used kratom, even though kratom is not a controlled substance or otherwise contraband.
-
February 27, 2026
Split 11th Circ. Vacates 20-Year Sentence In Fla. Gun Case
A split Eleventh Ciruit vacated a 20-year sentence for a Florida man convicted of gun- and drug-related charges following a jury trial, finding his crimes didn't count as violent in accordance with a 2022 U.S. Supreme Court decision.
-
February 27, 2026
Minn. State Sens. Introduce Medical Psilocybin Bill
A pair of Minnesota state senators have introduced a bill to create and regulate a medical psilocybin use program, which would allow residents over 21 with qualifying medical conditions to cultivate and use the drug to treat their conditions.
Areas of Coverage
- AGENCIES
- U.S. Food & Drug Administration
- Federal Trade Commission
- Drug Enforcement Agency
- U.S. Department of the Treasury
- California Bureau of Cannabis Control
- Department of Health & Human Services
- Financial Crimes Enforcement Network
- U.S. Securities and Exchange Commission
- U.S. Commodity Futures Trading Commission
- U.S. Department of Justice
- State and international regulators
- POLICY & REGULATION
- SAFE Banking Act
- STATES Act
- Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
- Section 280E of the Internal Revenue Code
- Rohrabacher–Farr amendment
- Bank Secrecy Act
- Federal and state legislation
- ENFORCEMENT
- FDA and FTC actions over cannabis’s purported health claims
- IRS actions against cannabis companies
- Antitrust investigations
- Financial regulatory actions
- Federal criminal matters
- State enforcement actions
- LITIGATION
- Civil RICO actions brought against cannabis concerns
- Employment disputes
- Securities class actions
- Intellectual property matters
- Consumer class actions
- Bankruptcy
- Tax disputes
- Challenges to federal or state regulations
- TRANSACTIONS
- M&A activity involving cannabis companies
- Commercial real estate transactions
- PROFILES
- Personnel moves
- Profiles of law firm cannabis practices
- Federal and state policymakers and lawmakers
- General counsel interviews
READERSHIP
- Cannabis lawyers at large to medium-sized law firms and boutiques
- In-house counsel, compliance officers and executives at cannabis companies
- Counsel and executives at venture capital and investment firms
- Policymakers at federal and state agencies
- Federal and state lawmakers
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.